Effects of a Microalgae Extract Dietary Supplement on Gut Health, Anxiety, and Immune Function
Launched by COLORADO STATE UNIVERSITY · May 17, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a daily supplement made from microalgae, called Tetrasol, might help improve gut health, reduce anxiety, and boost immune function. Researchers will measure changes in gastrointestinal symptoms and bowel habits, as well as check blood and saliva for signs of stress and inflammation. They also want to see if the supplement is safe for participants.
To be eligible for this study, you should be a healthy adult between 18 and 55 years old, with a body mass index (BMI) between 18.0 and 29.9, and experiencing mild to moderate gut issues. However, if you have certain medical conditions, are pregnant or breastfeeding, or use specific medications, you may not qualify. If you join the trial, you can expect regular check-ins and tests to monitor your health and how your body responds to the supplement. This study is currently recruiting participants, and your involvement could help researchers learn more about the potential benefits of microalgae for gut health and overall wellness.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy, normal to overweight (BMI of 18.0-29.9) adults between 18-55 years of age with mild to moderate gastrointestinal distress confirmed by one positive response to the Rome IV criteria (Appended).
- Exclusion Criteria:
- • BMI \>30.0 or \<18.0
- • Smoking or other use of tobacco products
- • Diagnosed intestinal diseases such as Celiac, Crohn's Disease, Ulcerative Colitis, or Gastrointestinal Cancers
- • Pregnant or breastfeeding individuals
- • Regular use of NSAIDs or MAO inhibitors
- • Clinically diagnosed mental health disorders (clinical depression, bipolar disorder, etc.)
Trial Officials
Tiffany L Weir, MSc,PhD
Principal Investigator
Colorado State University
About Colorado State University
Colorado State University (CSU) is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, CSU leverages its extensive expertise in veterinary medicine, biomedical sciences, and public health to conduct rigorous and ethically sound research. The university is committed to fostering a culture of scientific inquiry and community engagement, ensuring that its clinical trials not only contribute to the academic field but also address real-world health challenges. CSU's state-of-the-art facilities and access to diverse populations enable it to design and execute studies that aim to enhance understanding and treatment of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fort Collins, Colorado, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0